Panel rejects Merck over-the-counter statin bid
112661
A U.S. advisory panel  urged the government on Thursday to reject Merck & Co Inc's   latest bid to sell the first cholesterol-lowering drug  without a prescription.
256331
A US regulatory advisory panel has rejected Procter &amp; Gamble&#39;s female sexual dysfunction patch, saying the potential long-term risks of the hormone treatment outweighed the benefits.
223287
The panel said that while Americans could benefit from taking a Merck cholesterol-lowering drug, they should not begin such a regimen without a doctor's advice.
458929
U.S. health officials said on Friday  they would review whether to take regulatory action over Merck  & Co Inc and Schering-Plough's cholesterol medicine Vytorin  following the drug's failure to work better than a generic drug  in a study of plaque build-up in neck arteries.
525567
Drug maker Merck & Co. Inc.  urged U.S. advisers on Thursday to approve the first over-the-counter sales of a cholesterol-lowering pill, but regulators questioned if consumers would use it properly.
119824
A US federal judge refused to allow a class-action lawsuit to proceed against Merck for health problems linked to its Vioxx pain medication, in a major victory for the pharmaceutical giant.
762103
A federal judge on Wednesday denied a  motion for class-action status for personal injury and wrongful  death cases involving Merck & Co.'s  withdrawn Vioxx  painkiller.
171919
U.S. regulators said on Friday they  would review whether to take action over Merck & Co Inc's   and Schering-Plough Corp's  popular cholesterol  medicine Vytorin after a study showed it was no better than a  generic drug in preventing the build-up of fatty plaque.
681063
U.S. patent officials have initially rejected claims for the basic patent on Pfizer Inc's blockbuster Lipitor cholesterol treatment, although the drug maker said on Monday it remained confident the patent would ultimately be upheld.
455038
U.S. regulators said on Friday they would review whether to take action over Merck & Co Inc's and Schering-Plough Corp's popular cholesterol drug Vytorin after a study showed it was no better than a generic in preventing the build-up of fatty plaque.
637554
Federal health advisers recommended against over-the-counter sales of cholesterol drug Mevacor, saying that patients need medical guidance.
586727
Consumer advocates backed by some  prominent doctors and researchers on Thursday questioned a new  U.S. policy recommending wider use of statin drugs to lower  cholesterol.
740825
ATLANTIC CITY, New Jersey  - Merck & Co.  failed to provide adequate warnings about health risks tied to its withdrawn arthritis drug Vioxx in one case, but gave adequate warning in another, a New Jersey jury found on Friday in a split decision in two suits tried simultaneously.
335550
Government advisers rejected Merckâs bid for over-the-counter sales of a cholesterol-lowering drug, saying that too many people would mistakenly use the drug if it no longer required a prescription.
33756
Schering-Plough Corp and Merck & Co are defending their shared cholesterol treatments, Vytorin and Zetia, in advertisements after a failed study generated negative publicity.
479138
A U.S. federal judge has denied motions to certify classes of users of osteoporosis drug Fosamax who wanted Merck & Co  to set up a program to monitor them for an ailment involving jaw bone decay.
38442
Merck & Co. is making a third try to sell the granddaddy of the famed cholesterol-lowering statin drugs without a prescription.